Bristol-Myers Squibb Co. v. Novartis Pharma AG, No. 1:2022cv04162 - Document 13 (S.D.N.Y. 2022)

Court Description: MEMORANDUM DECISION AND ORDER DENYING RESPONDENT'S MOTION TO SEAL THE FINAL ARBITRATION AWARD: denying 7 Motion to Seal. Novartis's motion to seal the final arbitration award is DENIED. Novartis' alternative request to file a redac ted version of the final award is also DENIED except to the extent of allowing it to redact the sales amounts found on page 17 of the award. Novartis has until June 22, 2022 to inform the Court whether it wants the royalty information redacted where it appears at pages 16, 20, 22-23, 25-26, and 28. To that extent, the motion is GRANTED. The clerk is respectfully directed to close the open motion at Docket Number 7. This constitutes the decision and order of the Court. It is a written opinion. (Signed by Judge Colleen McMahon on 6/14/2022) (ama)

Download PDF
Bristol-Myers Squibb Co. v. Novartis Pharma AG Doc. 13 Dockets.Justia.com

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.